MicroRNAs in HIV-associated nephropathy (HIVAN)

Experimental and Molecular Pathology

Volumn 94, Issue 1, 2013, Pages 65-72

  Cheng, Kang ^a   Rai, Partab ^a   Plagov, Andrei ^a   Lan, Xiqian ^a   Subrati, Ashaan ^a   Husain, Mohammad ^a   Malhotra, Ashwani ^a   Singhal, Pravin C ^a  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

Epithelial mesenchymal transition; HIV transgenic mice; HIV associated nephropathy; MicroRNAs; Podocytes

Indexed keywords

MICRORNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HISTOPATHOLOGY; HIV ASSOCIATED NEPHROPATHY; HOMEOSTASIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PODOCYTE; REAL TIME POLYMERASE CHAIN REACTION;

AIDS-ASSOCIATED NEPHROPATHY; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION PROFILING; HIV INFECTIONS; HIV-1; HUMANS; KIDNEY; MICE; MICE, TRANSGENIC; MICRORNAS; PODOCYTES;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MUS; MUS MUSCULUS;

EID: 84870883234     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2012.10.011     Document Type: Article

References (52)

1. Atta M.G. Diagnosis and natural history of HIV-associated nephropathy. Advances in Chronic Kidney Disease 2010, 17:52-58.
2. Baskerville S., Bartel D.P. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005, 11:241-247.
3. Bhatt K., Zhou L., Mi Q.S., Huang S., She J.X., Dong Z. MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cells survival. Molecular Medicine 2010, 16:409-416.
4. Bhatt K., Mi Q.S., Dong Z. MicroRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. American Journal of Physiology. Renal Physiology 2011, 300:F602-F610.
5. Bonegio R.G., Fuhro R., Wang Z., Valeri C.R., Andry C., Salant D.J., Lieberthal W. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. Journal of the American Society of Nephrology 2005, 16:2063-2072.
6. Chandrasekaran K., Karolina D.S., Sepramaniam S., Armugam A., Wintour E.M., Bertram J.F., Jeyaseelan K. Role of microRNAs in kidney homeostasis and disease. Kidney International 2012, 81:617-627.
7. Chung A.C., Huang X.R., Meng X., Lan H.Y. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. Journal of the American Society of Nephrology 2010, 21:1317-1325.
8. Dai Y., Sui W., Lan H., Yan Q., Huang H., Huang Y. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatology International 2009, 29:749-754.
9. Ding X.C., Weiler J., Grosshans H. Regulating the regulators mechanisms controlling the maturation of microRNAs. Trends in Biotechnology 2009, 11:228-234.
10. Fornari F., Milazzo M., Chieco P., Negrini M., Calin G.A., Grazi G.L., Pollutri D., Croce C.M., Bolondi L., Gramantieri L. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Research 2010, 70:5184-5193.
11. Godwin J.G., Ge X., Stephan K., Jurisch A., Tullius S.G., Iacomini J. Identification of a microRNA signature of renal ischemia reperfusion injury. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:14339-14344.
12. Gottardo F., Liu C.G., Ferracin M., Calin G.A., Fassan M., Bassi P., Sevignani C., Byrne D., Negrini M., Pagano F., Gomella L.G., Croce C.M., Baffa R. Micro-RNA profiling in kidney and bladder cancers. Urologic Oncology 2007, 25:387-392.
13. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., Goodall G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature Cell Biology 2008, 10:593-601.
14. Harvey S.J., Jarad G., Cunningham J., Goldberg S., Schermer B., Harfe B.D., McManus M.T., Benzing T., Miner J.H. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease. Journal of the American Society of Nephrology 2008, 19:2150-2158.
15. Ho J., Ng K.H., Rosen S., Dostal A., Gregory R.I., Kreidberg J.A. Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. Journal of the American Society of Nephrology 2008, 19:2069-2075.
16. Husain M., Meggs L.G., Vashistha H., Simoes S., Griffiths K.O., Kumar D., Mikulak J., Mathieson P.W., Saleem M.A., Del Valle L., Pina-Oviedo S., Wang J.Y., Seshan S.V., Malhotra A., Reiss K., Singhal P.C. Inhibition of p66ShcA longevity gene rescues podocytes from HIV-1-induced oxidative stress and apoptosis. Journal of Biological Chemistry 2009, 284:16648-16658.
17. Jin Y., Ratnam K., Chuang P.Y., Fan Y., Zhong Y., Dai Y., Mazloom A.R., Chen E.Y., D'Agati V., Xiong H., Ross M.J., Chen N., Ma'ayan A., He J.C. A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nature Medicine 2012, 18:580-588.
18. Kasinath B.S., Feliers D. The complex world of kidney microRNAs. Kidney International 2011, 80:334-337.
19. Kato M., Arce L., Natarajan R. MicroRNAs and their role in progressive kidney diseases. Clinical Journal of the American Society of Nephrology 2009, 4:1255-1266.
20. Kato M., Arce L., Wang M., Putta S., Lanting L., Natarajan R. A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells. Kidney International 2011, 80:358-368.
21. Kaucsár T., Rácz Z., Hamar P. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease. Advanced Drug Delivery Reviews 2010, 62:1390-13401.
22. Kopp J.B., Klotman M.E., Adler S.H., Bruggeman L.A., Dickie P., Marinos N.J., Eckhaus M., Bryant J.L., Notkins A.L., Klotman P.E. Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:1577-1581.
23. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nature Reviews Genetics 2010, 11:597-610.
24. Kumar D., Konkimalla S., Yadav A., Sataranatarajan K., Kasinath B.S., Chander P.N., Singhal P.C. HIV-associated nephropathy: role of mammalian target of rapamycin pathway. American Journal of Pathology 2010, 177:813-821.
25. Kumar D., Luan L., Pathak S., Salhan D., Magoon S., Singhal P.C. Ang II enhances tubular cell Ets-1 expression and associated downstream signaling is mediated through AT1 receptors. Renal Failure 2010, 32:986-991.
26. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., Lin C., Socci N.D., Hermida L., Fulci V., Chiaretti S., Foà R., Schliwka J., Fuchs U., Novosel A., Müller R.U., Schermer B., Bissels U., Inman J., Phan Q., Chien M., Weir D.B., Choksi R., De Vita G., Frezzetti D., Trompeter H.I., Hornung V., Teng G., Hartmann G., Palkovits M., Di Lauro R., Wernet P., Macino G., Rogler C.E., Nagle J.W., Ju J., Papavasiliou F.N., Benzing T., Lichter P., Tam W., Brownstein M.J., Bosio A., Borkhardt A., Russo J.J., Sander C., Zavolan M., Tuschl T. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
27. Liang Y., Ridzon D., Wong L., Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007, 8:166.
28. Liu C.G., Calin G.A., Meloon B., Gamliel N., Sevignani C., Ferracin M., Dumitru C.D., Shimizu M., Zupo S., Dono M., Alder H., Bullrich F., Negrini M., Croce C.M. An oligonucleotide microchip for genomewide microRNA profiling in human and mouse tissues. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:9740-9744.
29. Lorenzen J.M., Haller H., Thum T. MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nature Reviews Nephrology 2011, 7:286-294.
30. Marras D., Bruggeman L.A., Gao F., Tanji N., Mansukhani M.M., Cara A., Ross M.D., Gusella G.L., Benson G., D'Agati V.D., Hahn B.H., Klotman M.E., Klotman P.E. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nature Medicine 2002, 8:522-526.
31. Mori H., Inoki K., Masutani K., Wakabayashi Y., Komai K., Nakagawa R., Guan K.L., Yoshimura A. The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochemical and Biophysical Research Communications 2009, 384:471-475.
32. Nagaraja A.K., Creighton C.J., Yu Z., Zhu H., Gunaratne P.H., Reid J.G., Olokpa E., Itamochi H., Ueno N.T., Hawkins S.M., Anderson M.L., Matzuk M.M. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Molecular Endocrinology 2010, 24:447-463.
33. Nicoletti F., Fagone P., Meroni P., McCubrey J., Bendtzen K. mTOR as a multifunctional therapeutic target in HIV infection. Drug Discovery Today 2011, 16:715-721.
34. Oneyama C., Ikeda J., Okuzaki D., Suzuki K., Kanou T., Shintani Y., Morii E., Okumura M., Aozasa K., Okada M. MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways. Oncogene 2011, 30:3489-3501.
35. Pandey P., Brors B., Srivastava P.K., Bott A., Boehn S.N., Groene H.J., Gretz N. Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease. BMC Genomics 2008, 9:624.
36. Park S.M., Gaur A.B., Lengyel E., Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes & Development 2008, 22:894-907.
37. Rane S., He M., Sayed D., Vashistha H., Malhotra A., Sadoshima J., Vatner D.E., Vatner S.F., Abdellatif M. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circulation Research 2009, 104:879-886.
38. Rehman S., Husain M., Yadav A., Kasinath B.S., Malhotra A., Singhal P.C. HIV-1 promotes renal tubular epithelial cell protein synthesis: role of mTOR pathway. PLoS One 2012, 7:e30071.
39. Ren Z., Liang W., Chen C., Yang H., Singhal P.C., Ding G. Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1. Cellular Signalling 2012, 24:443-450.
40. Saal S., Harvey S.J. MicroRNAs and the kidney: coming of age. Current Opinion in Nephrology and Hypertension 2009, 18:317-323.
41. Salhan D., Sagar A., Kumar D., Rattanavich R., Rai P., Maheshwari S., Adabala M., Husain M., Ding G., Malhotra A., Chander P.N., Singhal P.C. HIV-associated nephropathy: role of AT2R. Cellular Signalling 2012, 24:734-741.
42. Sarah S., Black M.A. Microarray-based gene set analysis: a comparison of current methods. BMC Bioinformatics 2008, 9:502.
43. Shi S., Yu L., Chiu C., Sun Y., Chen J., Khitrov G., Merkenschlager M., Holzman L.B., Zhang W., Mundel P., Bottinger E.P. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. Journal of the American Society of Nephrology 2008, 19:2159-2169.
44. Sun Y., Koo S., White N., Peralta E., Esau C., Dean N.M., Perera R.J. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Research 2004, 32:e188.
45. Tian Z., Greene A.S., Pietrusz J.L., Matus I.R., Liang M. MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Research 2008, 18:404-411.
46. Wang G., Kwan B.C., Lai F.M., Choi P.C., Chow K.M., Li P.K., Szeto C.C. Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. American Journal of Hypertension 2010, 23:78-84.
47. Wang B., Koh P., Winbanks C., Coughlan M.T., McClelland A., Watson A., Jandeleit-Dahm K., Burns W.C., Thomas M.C., Cooper M.E., Kantharidis P. miR-200a prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes 2011, 60:280-287.
48. Winter J., Jung S., Keller S., Gregory R.I., Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nature Cell Biology 2009, 11:228-234.
49. Xiong M., Jiang L., Zhou Y., Qiu W., Fang L., Tan R., Wen P., Yang J. The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. American Journal of Physiology. Renal Physiology 2012, 302:F369-F379.
50. Yadav A., Vallabu S., Kumar D., Ding G., Charney D.N., Chander P.N., Singhal P.C. HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation. American Journal of Physiology. Renal Physiology 2010, 298:F734-F744.
51. Yadav A., Kumar D., Salhan D., Rattanavich R., Maheshwari S., Adabala M., Ding G., Singhal P.C. Sirolimus modulates HIVAN phenotype through inhibition of epithelial mesenchymal transition. Experimental and Molecular Pathology 2012, 93:173-181.
52. Yuan J.S., Reed A., Chen F., Stewart C.N. Statistical analysis of real-time PCR data. BMC Bioinformatics 2006, 7:1471-2105.